Table 3 Recipients of LCL-21353.2F8-23482 (group 2 mice)
From: Development of transplantable B-cell lymphomas in the MHC-defined miniature swine model
Mouse | IV dose | IP dose | Clinical assessment | Day |
|---|---|---|---|---|
41 | 1 × 107 | 0.5 × 107 | Moderate hind limb paralysis, hunched posture, decreased activity | 35 |
42 | 1 × 107 | 0.5 × 107 | Moderate hind limb paralysis, hunched posture, decreased activity | 35 |
43 | 1 × 107 | – | Moderate hind limb paralysis, hunched posture, decreased activity | 35 |
44 | 1 × 107 | 0.5 × 107 | Hunched posture, decreased activity | 62 |